Your browser doesn't support javascript.
loading
Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand.
Chongmelaxme, Bunchai; Phisalprapa, Pochamana; Manthaisong, Ratree; Dilokthornsakul, Piyameth; Chaiyakunapruk, Nathorn.
Afiliação
  • Chongmelaxme B; Center of Pharmaceutical Outcomes Research, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, 65000, Phitsanulok, Thailand.
  • Phisalprapa P; Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Manthaisong R; Clinical Pharmacy Research Unit, Department of Clinical Pharmacy, Faculty of Pharmacy, Mahasarakham University, Mahasarakham, Thailand.
  • Dilokthornsakul P; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia.
  • Chaiyakunapruk N; Center of Pharmaceutical Outcomes Research, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, 65000, Phitsanulok, Thailand. piyamethd@gmail.com.
Pharmacoeconomics ; 37(2): 291, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30547370
ABSTRACT
Weight Reduction is Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Aspecto: Patient_preference Idioma: En Revista: Pharmacoeconomics Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Aspecto: Patient_preference Idioma: En Revista: Pharmacoeconomics Ano de publicação: 2019 Tipo de documento: Article